Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
|---|---|---|---|
| Operating cash flow (direct method) | |||
| Cash income from operating activities | |||
| Cash paid | -27.07%-1.09M | -61.69%-860.56K | -532.23K |
| Payments to suppliers for goods and services | -27.07%-1.09M | -61.69%-860.56K | ---532.23K |
| Direct interest received | 39.67%203.92K | --146K | ---- |
| Operating cash flow | -24.50%-889.59K | -34.26%-714.56K | ---532.23K |
| Investing cash flow | |||
| Cash flow from continuing investing activities | -225.67%-4.98M | -221.48%-1.53M | -475.2K |
| Capital expenditure reported | -222.14%-4.45M | -194.37%-1.38M | ---469.36K |
| Net PPE purchase and sale | ---- | 57.00%-2.51K | ---5.83K |
| Net business purchase and sale | ---609.83K | ---- | ---- |
| Net investment purchase and sale | 159.68%85.63K | ---143.47K | ---- |
| Net other investing changes | --140.17K | ---- | ---- |
| Cash from discontinued investing activities | |||
| Investing cash flow | -225.67%-4.98M | -221.48%-1.53M | ---475.2K |
| Financing cash flow | |||
| Cash flow from continuing financing activities | 17,683.96%5.47M | -100.37%-31.12K | 8.37M |
| Net common stock issuance | --5.51M | ---- | --7.78M |
| Net other financing activities | -35.91%-84.59K | -110.81%-62.24K | --575.82K |
| Cash from discontinued financing activities | |||
| Financing cash flow | 17,683.96%5.47M | -100.37%-31.12K | --8.37M |
| Net cash flow | |||
| Beginning cash position | -30.87%5.09M | --7.36M | ---- |
| Current changes in cash | 82.74%-392.46K | -130.87%-2.27M | --7.36M |
| End cash Position | -7.71%4.7M | -30.87%5.09M | --7.36M |
| Free cash from | -152.06%-5.34M | -110.31%-2.12M | ---1.01M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP |